SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001214659-17-004929
Filing Date
2017-08-10
Accepted
2017-08-10 16:11:23
Documents
53
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 d8417110q.htm 10-Q 645743
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 7893
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 7901
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 4866
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 4997
  Complete submission text file 0001214659-17-004929.txt   3411112

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT hgen-20170630.xml EX-101.INS 626532
7 XBRL TAXONOMY EXTENSION SCHEMA hgen-20170630.xsd EX-101.SCH 37455
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hgen-20170630_cal.xml EX-101.CAL 43513
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hgen-20170630_def.xml EX-101.DEF 157176
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE hgen-20170630_lab.xml EX-101.LAB 290224
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hgen-20170630_pre.xml EX-101.PRE 219432
Mailing Address 1000 MARINA BOULEVARD SUITE 250 BRISBANE CA 94005-1878
Business Address 1000 MARINA BOULEVARD SUITE 250 BRISBANE CA 94005-1878 650.243.3100
HUMANIGEN, INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35798 | Film No.: 171021582
SIC: 2834 Pharmaceutical Preparations